Recent Updates
Recently added Catalysts
ORBIMED ADVISORS LLC
Track ORBIMED ADVISORS LLC's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Sep 18, 2026
Showing 6 Stocks Out Of 119. Click On The Tickers For More Details
| Stock | Compnay Name | Shares Held | Market Value | % of Portfolio | QoQ Change |
|---|---|---|---|---|---|
 FBRX | FORTE BIOSCIENCES INC | 1.58 M | 33.53 M | 0.6 | |
 QTTB | Q32 BIO INC | 4.13 M | 52.59 M | 1 | |
 CRNX | CRINETICS PHARMACEUTICALS IN | 999.00 K | 37.38 M | 0.7 | |
 MBX | MBX BIOSCIENCES INC | 3.43 M | 189.27 M | 3.5 | |
 DFTX | DEFINIUM THERAPEUTICS INC | 365.40 K | 17.19 M | 0.3 | |
 MNPR | MONOPAR THERAPEUTICS INC | 157.42 K | 14.57 M | 0.3 |
Market Value
$ 5.21 B
Holdings
119
Period
Q2 2026
Holdings in Top 20
%
QoQ Changes
6.97 %